News Search Results

Displaying Results 101-125 of 250 "synthetic biology"

Jan 09, 2024, 14:15 ET Global Synthetic Biology Market Analysis Report, 2022 and 2023-2028: Rising Potential in Consumer Goods, Utilization of AI, Rising Demand for Bio-based Products, Increase in Synthetic Vaccines

Increasing Utilization of AI in Synthetic BiologyExpansion in Agriculture and Food ProductionTechnological InnovationsRising Potential of Synthetic Biology in Consumer GoodsThe key players of the global synthetic biology market are: Thermo

More news about: Research and Markets


Jan 08, 2024, 08:30 ET AION Labs Welcomes Amiti as Strategic Partner to Accelerate Israel's Position as a Leading Hub for Transformative AI-Powered Drug Discovery Innovation

best deep tech founders that have the potential to disrupt and dominate major markets. Amiti targets quantum computing and computational and synthetic biology, where Israel has some of the most promising founders, expertise and multi-disciplinary skills in the world.

More news about: AION Labs


Jan 08, 2024, 07:00 ET Ginkgo Bioworks Announces Inaugural Members of New Biopharma Advisory Board

said Jason Kelly, co-founder and CEO of Ginkgo Bioworks. "Advanced technologies in high throughput automation, synthetic biology, and more recently AI, have opened up possibilities for the development of novel modalities and exploration of more design space for the discovery

More news about: Ginkgo Bioworks


Jan 04, 2024, 17:11 ET Sterne Kessler Elects Six New Directors in 2024

Specifically, his work frequently involves cell and gene therapies, biologics, small molecule drugs, antibody technology, molecular diagnostics, and synthetic biology. Christopher's experience includes advising clients, from early-stage start-ups to large corporations, on intellectual property issues that arise

More news about: Sterne, Kessler, Goldstein & Fox


Jan 04, 2024, 07:00 ET Ginkgo Bioworks Completes Program with Biogen to Boost Productivity of Gene Therapy Manufacturing Platform

and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,

More news about: Ginkgo Bioworks


Jan 04, 2024, 04:37 ET GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector

to downstream high-value-added businesses. The company has a solid endogenous power through internal incubation and layout in the CRO, CDMO, synthetic biology product, and cell therapy fields. The JPM Healthcare Conference, as the weather vane of the global healthcare industry, brings together

More news about: GenScript Biotech Corporation


Dec 22, 2023, 10:30 ET Biosensors and Nanosensors Global Market Report - A $43.5 Billion Market by 2028, Growing at a CAGR of 7.3% from 2023 to 2028

DominanceWearable BiosensorsPoint-of-Care TestingIoT IntegrationEmerging TechnologiesGraphene-Based BiosensorsSynthetic Biology and Genetic EngineeringNanoparticles and Quantum DotsLab-on-a-Chip (LOC)MicrofluidicsAI and ML3D

More news about: Research and Markets


Dec 22, 2023, 05:00 ET Precision Fermentation Technology Outlook - Integration of AI and Robotics, Emerging Synthetic Biology Technologies and Growing Vegan Population Presents Key Growth Opportunities

production. Notably, synthetic biology start-ups are increasingly influencing advances in precision fermentation by enabling the designing of ingredients, making the field a promising growth opportunity for biotechnology companies. Advancements in AI, robotics, and synthetic biology technologies are enabling

More news about: Research and Markets


Dec 20, 2023, 12:00 ET CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors

cells such as CAR-iMAC. They have obtained engineered immune cells derived from iPSC using cutting-edge technologies including gene editing and synthetic biology.  CellOrigin takes advantage of the unique characteristics of macrophages that can infiltrate the solid tumor microenvironment (TME), and

More news about: CellOrigin


Dec 20, 2023, 08:45 ET RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola

synergistic effect in combination with remdesivir," said Jeffrey Kugelman, Ph.D., Major(P), US Army MSC, Branch Chief Synthetic Biology & Surveillance, Molecular Biology Division, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), who led the bioinformatics

More news about: RedHill Biopharma Ltd.


Dec 20, 2023, 07:00 ET OneOne Biosciences Partners with Ginkgo Bioworks to Advance its Platform and Nitrogen Fixation Microbial Product

startup developing a comprehensive suite of agricultural microbial solutionsGinkgo will support OneOne in its agricultural biologicals and synthetic biology R&DGinkgo will initially conduct in vitro and in planta assays to test OneOne's concept. In a planned second phase,

More news about: Ginkgo Bioworks


Dec 19, 2023, 07:01 ET U.S. Department of Energy Awards Team Led by Ginkgo Bioworks Funding to Develop Algal Crop Protection Solutions

and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,

More news about: Ginkgo Bioworks


Dec 19, 2023, 07:01 ET FGen AG, a Ginkgo Bioworks Subsidiary, Awarded Funding Through European Innovation Council's Pathfinder Programme For Sustainable Milk Protein Production Project

and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,

More news about: Ginkgo Bioworks


Dec 19, 2023, 07:01 ET GreenLab Selects Ginkgo Enzyme Services to Develop Novel Enzyme That Breaks Down 'Forever Chemicals'

and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,

More news about: Ginkgo Bioworks


Dec 19, 2023, 07:00 ET Ayana Bio Welcomes Industry Veteran Jim Hamilton to its Board of Directors

animal care and skin care to bring the power of plant bioactives to the mass market at scale. Ayana Bio has partnered with the global leader in synthetic biology, Ginkgo Bioworks, to select, optimize and scale plant cell-cultivated ingredients. Ayana Bio is backed by prestigious investors, Viking Global

More news about: Ayana Bio


Dec 18, 2023, 09:13 ET Tsingke Congratulates iGEM 2023 SYSU-Software on Winning GOLD MEDAL for BioRocket Project

individuals to commit themselves to the research of synthetic biology, contributing to the advancement of this industry. About iGEM The iGEM competition is an internationally renowned academic competition in the field of synthetic biology. It was initiated by the Massachusetts

More news about: Beijing Tsingke Biotech Co., Ltd.


Dec 13, 2023, 16:00 ET The BioWell Accelerator, a First Bight-Led initiative, Receives Prestigious Federal Grant

BioWell, a nonprofit accelerator aimed at early-stage synthetic biology startups, was awarded $741,925. Funding will be used to support a vibrant bioeconomy by accelerating the

More news about: First Bight Ventures


Dec 13, 2023, 13:30 ET Global Enzymatic DNA Synthesis Market Report 2023-2028, Featuring Profiles of Telesis Bio, Twist Bioscience ,GenScript Biotech, Evonetix, Camena Bio, Molecular Assemblies, Touchlight and Kern Systems

diagnostics, making it a preferred choice among researchers and clinicians for its efficiency and reliability.By Application: The Synthetic biology segment dominated the market in 2022. This segment's adoption is driven by the need for creating synthetic genes, pathways, and organisms for

More news about: Research and Markets


Dec 13, 2023, 10:15 ET Global Bioinformatics Market Set to Hit $39.80 billion, Growing at 18.70% CAGR, Fueled by Increased Demand for Personalized Healthcare, Projects Kings Research

market presence in different regions. For instance, in April 2023, Absci, a prominent player in the field of synthetic biology, partnered with M2GEN, a company specializing in bioinformatics, with the objective of expediting the drug development process focused on oncology.

More news about: Kings Research


Dec 13, 2023, 07:01 ET Ginkgo Bioworks Receives Grant to Develop Innovative Live Cell Delivery Platform of Antibody Therapeutics for Treating HIV and Malaria

and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,

More news about: Ginkgo Bioworks


Dec 12, 2023, 21:15 ET Synthetic biology market size to grow by USD 28.25 billion from 2022 to 2027, the evolving regulatory framework around synthetic biology is the market trend - Technavio

institutions is expected to drive the growth of the synthetic biology market in the region during the forecast period.Market dynamics The growing applications of synthetic biology are driving the market growth. Synthetic biology helps improve the efficiency of products such

More news about: Technavio


Dec 12, 2023, 07:01 ET Arbor Biotechnologies Announces Collaboration with Ginkgo Bioworks to Advance the Discovery and Development of Precision Gene Editors

and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (v) changes to the biosecurity industry,

More news about: Ginkgo Bioworks


Dec 12, 2023, 06:30 ET Animal Parasiticides Market is Anticipated to Reach USD 15.6 billion, at a CAGR of 5.7% CAGR by 2031 - Report by Transparency Market Research Inc.

from 2022 to 2031 Synthetic Biology Market- The global market is anticipated to reach more than US$ 74.7 Bn by the end of 2031 and the

More news about: Transparency Market Research


Dec 11, 2023, 04:01 ET Hematology Diagnostics Market to Reach $16.87 Billion, Globally, by 2032 at 4.4% CAGR: Allied Market Research

Industry Forecast, 2022-2032 Synthetic Biology Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

More news about: Allied Market Research


Dec 08, 2023, 09:00 ET Alveolus Bio Enters Into Strategic Collaboration with BiomEdit

announced a strategic scientific collaboration with BiomEdit, an emerging animal health biotechnology company leveraging microbiome science and synthetic biology to develop novel products to prevent and treat disease in animals. BiomEdit, founded in 2022, originated through a carveout from Elanco Animal

More news about: Alveolus Bio, Inc and BiomEdit